Scott Davidoff, MD
Physical Medicine & Rehabilitation · King Of Prussia, PANPI 1053434399
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,500 of the $35,921 with a category attached, or 62.6%. MDD US Operations, LLC accounts for 85.3% of it on its own, with 43 other manufacturers making up the rest. Reporting peaked in 2019 at $28,127 and has fallen 97.5% since, to $716 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $101.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$31K
- Abbott$2K
- Boston Scientific$524
- Vertos Medical, Inc.$252
- Painteq LLC$245
- Curonix LLC$221
- plus $2K from 38 others
Across 101 payments — averaging $3259.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seikagaku Corporation$146K
- SPR Therapeutics, Inc$108K
- Averitas Pharma Inc.$72K
- Curonix LLC$2K
- Stimwave Technologies Incorporated$1K
What the payments were for
- Consulting fees$3,70010%
- Speaking & faculty fees$22,50063%
- Travel & lodging$2,7918%
- Food & beverage$6,87119%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,921 in reported general payments places this provider in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl ErTramadol Hcl | 27 | $1,426 |
| Gabapentin | 150 | $1,188 |
| Duloxetine Hcl | 80 | $787 |
| Pregabalin | 62 | $564 |
| Oxycodone Hcl | 26 | $402 |
| Celecoxib | 16 | $384 |
| Tizanidine Hcl | 53 | $317 |
| Meloxicam | 79 | $307 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $157 |
| Tramadol Hcl | 30 | $118 |
| Methylprednisolone | 29 | $114 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in King Of Prussia
- Jeffery RoweKing Of Prussia$1.9M
- Farzad KarkvandeianKing Of Prussia$30K
- Roy LermanKing Of Prussia$7K
- Eric LiuKing Of Prussia$6K
- Denis RogersKing Of Prussia$3K
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
- Alberto EsquenaziPhiladelphia$305K
- Mitchell PaulinPaoli$229K
- Kimberly HeckertPhiladelphia$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.